ストックスクリーナーアプリを入手
14.22
1.21%
0.17
アフターアワーズ：
14.22
前日終値:
$14.05
開ける：
$14.04
24時間の取引高:
904.82K
Relative Volume:
0.51
時価総額：
$45.08B
収益：
$29.58B
当期純損益:
$974.15M
株価収益率:
32.03
EPS:
0.444
ネットキャッシュフロー:
$3.13B
1週間 パフォーマンス:
+2.67%
1か月 パフォーマンス:
-1.46%
6か月 パフォーマンス:
+6.36%
1年 パフォーマンス:
+1.50%
1日の値動き範囲:
$14.04
$14.24
1週間の範囲:
$13.77
$14.24
52週間の値動き範囲:
$12.57
$15.08
Takeda Pharmaceutical Co Adr Stock (TAK) Company Profile
Takeda Pharmaceutical Co Adr Stock (TAK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-03-16 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-07-19 | アップグレード | Cowen | Market Perform → Outperform |
| 2021-10-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2019-11-01 | 開始されました | Cowen | Market Perform |
| 2019-08-15 | ダウングレード | Daiwa Securities | Outperform → Neutral |
すべてを表示
Takeda Pharmaceutical Co Adr (TAK) 最新ニュース
Prediabetes Market to hit USD 360.6 million by 2032, says Global Market Insights Inc. - GlobeNewswire Inc.
Earnings call: Takeda reports robust H1 growth, revises full-year guidance - Investing.com Australia
Earnings call: Takeda reports robust H1 growth, revises full-year guidance By Investing.com - Investing.com South Africa
Torm Plc (NASDAQ: TRMD): Getting A Free Pass? - Stocks Register
What Analysts Were Expecting After Checkpoint Therapeutics Inc (NASDAQ: CKPT) rose 2.03% - Stocks Register
Weekly Upgrades and Downgrades - InvestorPlace
Dyne Therapeutics Inc (DYN) gets rating Reiterated from Chardan Capital Markets - Knox Daily
W & T Offshore Inc (WTI) receives a Buy rating from Stifel - Knox Daily
JP Morgan Upgrades Mister Car Wash Inc (MCW) to an Overweight from a Neutral - Knox Daily
BofA Securities upgrades Takeda Pharmaceutical Co ADR (TAK) rating to a Buy - Knox Daily
What Did We Find About Insider Trading At Ovintiv Inc (NYSE: OVV)? - Stocks Register
Mizuho analysts downgrades a Neutral rating for Squarespace Inc (SQSP) - Knox Daily
Barclays gives an Equal weight recommendation for Kilroy Realty Corp. (KRC) - Knox Daily
Microchip Technology, Inc. (MCHP) receives a Hold rating from Truist - Knox Daily
Cantor Fitzgerald’s latest rating for EBAY stock - Knox Daily
Watch this stock’s price performance: Takeda Pharmaceutical Co ADR (NYSE:TAK) - US Post News
North America Retinal Disorder Treatment Market Size & Outlook, 2030 - Grand View Research
Mexico Retinal Disorder Treatment Market Size & Outlook, 2030 - Grand View Research
China Retinal Disorder Treatment Market Size & Outlook, 2030 - Grand View Research
Italy Retinal Disorder Treatment Market Size & Outlook, 2030 - Grand View Research
Checking in on Takeda Pharmaceutical Co ADR (TAK) after recent insiders movement - Knox Daily
AHH stock rated a Buy by Stifel - Knox Daily
IgA nephropathy Clinical Trials 2024 (Updated): FDA Approvals, - openPR
IgA nephropathy Clinical Trials 2024 (Updated): FDA Approvals, Pipeline, Medication, Therapies, Treatment Market and Companies by DelveInsight - Barchart
Ratios in Focus: Analyzing Takeda Pharmaceutical Co ADR (TAK)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Taking a look at what insiders are doing to gauge the Takeda Pharmaceutical Co ADR (TAK)’s direction - Knox Daily
Brookline Bancorp, Inc. [BRKL] Records 50-Day SMA of $10.01 - Knox Daily
Crescent Energy Co. [CRGY] Records 200-Day SMA of $11.56 - Knox Daily
Tetra Tech, Inc. [TTEK] EVP, CFO makes an insider purchase of 36,830 shares worth 1.72 million. - Knox Daily
TAK’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle
Vatroslav Mateljic Appointed General Manager of Takeda Canada - Quantisnow
Ipsen provides update on CONTACT-02 Phase III trial in - GlobeNewswire
Biotech Soars, And Then Dives, On $5 Billion Opportunity - Investor's Business Daily
France Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research
Middle East & Africa Inflammatory Bowel Disease Treatment Market Size & Outlook, 2030 - Grand View Research
Saudi Arabia Plasma Fractionation Market Size & Outlook, 2030 - Grand View Research
The UAE Inflammatory Bowel Disease Treatment Market Size & Outlook, 2030 - Grand View Research
Asia Pacific Inflammatory Bowel Disease Treatment Market Size & Outlook, 2030 - Grand View Research
Japan Inflammatory Bowel Disease Treatment Market Size & Outlook, 2030 - Grand View Research
Kuwait Gout Therapeutics Market Size & Outlook, 2023-2030 - Grand View Research
Takeda Pharmaceutical Co ADR (TAK) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Cancer Cachexia Market Forecasted to Reach $3.14 Billion by 2028 with a CAGR of 6.2% - GlobeNewswire Inc.
Retinoblastoma Treatment Market to Surpass $2 Billion in 2024, Exhibiting a CAGR of 5.5% - GlobeNewswire Inc.
Targeted Therapeutics Market is Pioneering Growth Towards a USD 118.6 Billion Milestone by 2031, with a CAGR of 6.4% - GlobeNewswire Inc.
Takeda Pharmaceutical Co ADR (TAK) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Teva Pharmaceutical Industries Limited (TEVA) Stock Price, News, Quote & History - Yahoo Finance
Takeda Pharmaceutical Co Adr (TAK) 財務データ
収益
当期純利益
現金流量
EPS
0.10%
大文字化:
|
ボリューム (24 時間):